Press Releases | Clarus Therapeutics, Inc

Skip to main navigation

Investor Overview
News & Events
- Press Releases
- Events and Presentations
Stock Information
Corporate Governance
Financials & Filings
- SEC Filings
- Quarterly & Annual Reports
IR Resources
- Email Alerts
- Contact IR

Press Releases

Year

Dec 07, 2021

Clarus Therapeutics Announces Closing of Approximately $15 Million Private Placement

Dec 03, 2021

Clarus Therapeutics Announces $15 Million Private Placement

Nov 30, 2021

Clarus Therapeutics Announces Issuance of Two New Patents for JATENZO® (testosterone undecanoate)

Nov 18, 2021

Clarus Therapeutics Reports Third Quarter 2021 Financial and Operating Results

Nov 17, 2021

Clarus Therapeutics to Report Third Quarter 2021 Financial and Operating Results

Oct 26, 2021

Clarus Therapeutics Announces Two Notices of Allowance for Patent Claims Covering JATENZO® (testosterone undecanoate)

Oct 14, 2021

Clarus Therapeutics to Present New Real-World Experience Data for JATENZO® (testosterone undecanoate) at the 22nd Annual Fall Scientific Meeting of SMSNA

Sep 22, 2021

Clarus Therapeutics to Present at the 2021 Cantor Virtual Global Healthcare Conference

Sep 16, 2021

Clarus Therapeutics and McGill University Announce Exclusive Worldwide Licensing Agreement To Develop and Commercialize Technology To Treat Rare Conditions Associated With Coenzyme-Q10 (Ubiquinone) Deficiencies

Sep 15, 2021

Clarus Therapeutics to Present at the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit

Pagination

Current page 1
Page 2
Next page
Last page

Displaying 1 - 10 of 17

2022 Copyright

Search Investor Relations